Avanza Fonder Ab Cerus Corp Transaction History
Avanza Fonder Ab
- $3.05 Trillion
- Q1 2025
A detailed history of Avanza Fonder Ab transactions in Cerus Corp stock. As of the latest transaction made, Avanza Fonder Ab holds 110,315 shares of CERS stock, worth $145,615. This represents 0.01% of its overall portfolio holdings.
Number of Shares
110,315
Previous 109,852
0.42%
Holding current value
$145,615
Previous $169 Million
8.71%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CERS
# of Institutions
160Shares Held
146MCall Options Held
48.6KPut Options Held
8.7K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl20.8MShares$27.5 Million0.28% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$25.7 Million0.33% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$18.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$13.7 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.32MShares$11 Million0.06% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $234M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...